Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Optic neuritis--diagnosis, treatment and follow up].
Midgard R, Seland JH, Hovdal H, Celius EG, Eriksen K, Jensen D, Heger H, Mellgren SI, Wexler A, Beiske AG, Myhr KM. Midgard R, et al. Among authors: beiske ag. Tidsskr Nor Laegeforen. 2005 Feb 17;125(4):425-8. Tidsskr Nor Laegeforen. 2005. PMID: 15742012 Free article. Retracted. Norwegian.
[New diagnostic criteria in multiple sclerosis].
Midgard R, Beiske AG, Celius EG, Jensen D, Hovdal H, Mellgren SI, Myhr KM. Midgard R, et al. Among authors: beiske ag. Tidsskr Nor Laegeforen. 2003 May 15;123(10):1345-8. Tidsskr Nor Laegeforen. 2003. PMID: 12806674 Review. Norwegian. No abstract available.
[Retraction of article].
Midgard R, Seland JH, Hovdal H, Celius EG, Eriksen K, Jensen D, Heger H, Mellgren SI, Wexler A, Beiske AG, Myhr KM. Midgard R, et al. Among authors: beiske ag. Tidsskr Nor Laegeforen. 2005 Aug 11;125(15):2056. Tidsskr Nor Laegeforen. 2005. PMID: 16208878 Norwegian. No abstract available.
Body mass index influence interferon-beta treatment response in multiple sclerosis.
Kvistad SS, Myhr KM, Holmøy T, Šaltytė Benth J, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Michelsen AE, Aukrust P, Ueland T, Sagen JV, Torkildsen Ø. Kvistad SS, et al. Among authors: beiske ag. J Neuroimmunol. 2015 Nov 15;288:92-7. doi: 10.1016/j.jneuroim.2015.09.008. Epub 2015 Sep 26. J Neuroimmunol. 2015. PMID: 26531700 Clinical Trial.
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
Kvistad S, Myhr KM, Holmøy T, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Løken-Amsrud KI, Lilleås F, Midgard R, Njølstad G, Pedersen T, Benth JŠ, Wergeland S, Torkildsen O. Kvistad S, et al. Among authors: beiske ag. Mult Scler. 2014 Dec;20(14):1833-40. doi: 10.1177/1352458514533843. Epub 2014 May 19. Mult Scler. 2014. PMID: 24842958
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.
Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Šaltytė Benth J, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T. Røsjø E, et al. Among authors: beiske ag. J Neuroimmunol. 2015 Mar 15;280:21-8. doi: 10.1016/j.jneuroim.2015.02.001. Epub 2015 Feb 11. J Neuroimmunol. 2015. PMID: 25773151
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.
Sorensen PS, Mellgren SI, Svenningsson A, Elovaara I, Frederiksen JL, Beiske AG, Myhr KM, Søgaard LV, Olsen IC, Sandberg-Wollheim M. Sorensen PS, et al. Among authors: beiske ag. Lancet Neurol. 2009 Jun;8(6):519-29. doi: 10.1016/S1474-4422(09)70085-7. Epub 2009 May 4. Lancet Neurol. 2009. PMID: 19409854 Free article. Clinical Trial.
54 results